Orchestra BioMed Holdings, Inc 10-Q for FY2024 Q3
Orchestra BioMed Holdings, Inc. (OBIO)
10-Q
2024-11-12
For: 2024-09-30
View Original
Added on
April 06, 2026
About this 10-Q
Orchestra BioMed Holdings, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).
Headline figures
Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $987K
- up 135.6% from $419K a year earlier
- Net loss
- $15.43M
- compared with a net loss of $13.32M a year earlier
- Diluted EPS
- -$0.41
- compared with -$0.38 a year earlier